Zepbound News

Can Microdosing GLP-1s Like Wegovy, Zepbound Help You Lose Weight? - Healthline

Can Microdosing GLP-1s Like Wegovy, Zepbound Help You Lose Weight? Healthline

Eli Lilly study aims to bolster case for long-term Zepbound benefits - Fierce Healthcare

Eli Lilly study aims to bolster case for long-term Zepbound benefits Fierce Healthcare

If you’re on GLP-1 drugs and plan to fast for Yom Kippur, here’s what you need to know - The Conversation

If you’re on GLP-1 drugs and plan to fast for Yom Kippur, here’s what you need to know The Conversation

Zepbound linked to lower healthcare costs in adults over age 55 with obesity according to a real-world study - Eli Lilly

Zepbound linked to lower healthcare costs in adults over age 55 with obesity according to a real-world study Eli Lilly

Zepbound Vs. Mounjaro: What’s The Difference? - Forbes

Zepbound Vs. Mounjaro: What’s The Difference? Forbes

My family lost 147 pounds on Zepbound. Make it affordable to everyone. - IndyStar

My family lost 147 pounds on Zepbound. Make it affordable to everyone. IndyStar

What most people get wrong about GLP-1 drugs like Ozempic, Wegovy and Zepbound - CBS News

What most people get wrong about GLP-1 drugs like Ozempic, Wegovy and Zepbound CBS News

Lilly's Zepbound remains physicians' favorite, even as oral obesity launches alter landscape - Fierce Pharma

Lilly's Zepbound remains physicians' favorite, even as oral obesity launches alter landscape Fierce Pharma

How to Use LillyDirect for Zepbound and Foundayo Prescriptions - U.S. News & World Report

How to Use LillyDirect for Zepbound and Foundayo Prescriptions U.S. News & World Report

Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report - Pharmaceutical Executive

Study Shows Link Between Zepbound and Lower Healthcare Costs in Adults Aged 55 and Up with Obesity: Report Pharmaceutical Executive

GLP-1s 101: What the science says about weight loss, side effects, safety - Stanford Medicine

GLP-1s 101: What the science says about weight loss, side effects, safety Stanford Medicine

AI uncovers hidden Ozempic side effects across 400,000 Reddit posts - ScienceDaily

AI uncovers hidden Ozempic side effects across 400,000 Reddit posts ScienceDaily

Medicare's pilot GLP-1 discount program has a catch. Some sick patients don't qualify - NPR

Medicare's pilot GLP-1 discount program has a catch. Some sick patients don't qualify NPR

Lilly to present new data on Foundayo, retatrutide, and eloraTZP at EASD 2026, as it strives to change the course of cardiometabolic health - PR Newswire

Lilly to present new data on Foundayo, retatrutide, and eloraTZP at EASD 2026, as it strives to change the course of cardiometabolic health PR Newswire

Zepbound Lowers Health Care Costs in Older Adults With Obesity - Drug Topics

Zepbound Lowers Health Care Costs in Older Adults With Obesity Drug Topics

New Phase 3b data on Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults with psoriatic disease and obesity - Eli Lilly

New Phase 3b data on Lilly's Taltz (ixekizumab) and Zepbound (tirzepatide) used together showed improved and durable efficacy at one year in adults with psoriatic disease and obesity Eli Lilly

Retatrutide for Weight Loss: What to Know About the "Triple-Agonist" Drug - U.S. News & World Report

Retatrutide for Weight Loss: What to Know About the "Triple-Agonist" Drug U.S. News & World Report

What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management - Eli Lilly

What Medicare Part D patients need to know about accessing Foundayo (orforglipron) and Zepbound (tirzepatide) for weight management Eli Lilly

Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials - Eli Lilly

Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials Eli Lilly

Foundayo and Zepbound now covered for millions of Americans - Eli Lilly

Foundayo and Zepbound now covered for millions of Americans Eli Lilly

Compounded Ozempic, Zepbound Still Widely Available Despite End Of Drug Shortages - U.S. News & World Report

Compounded Ozempic, Zepbound Still Widely Available Despite End Of Drug Shortages U.S. News & World Report

'Microdosing' GLP-1s can shed pounds, but here are the dangers - USA Today

'Microdosing' GLP-1s can shed pounds, but here are the dangers USA Today

Zepbound® (tirzepatide) and Shaquille O'Neal launch national campaign after NBA legend learns the obstructive sleep apnea he has lived with for years is treatable - Eli Lilly

Zepbound® (tirzepatide) and Shaquille O'Neal launch national campaign after NBA legend learns the obstructive sleep apnea he has lived with for years is treatable Eli Lilly

CVS Caremark Ordered to Defend Lawsuit Over Zepbound Coverage - Bloomberg Law News

CVS Caremark Ordered to Defend Lawsuit Over Zepbound Coverage Bloomberg Law News

Why it may become harder to get coverage for GLP-1 weight-loss drugs - The Washington Post

Why it may become harder to get coverage for GLP-1 weight-loss drugs The Washington Post

Eli Lilly Eyes Obesity Access Expansion With Zepbound, Foundayo and Pipeline Bets - Yahoo Finance

Eli Lilly Eyes Obesity Access Expansion With Zepbound, Foundayo and Pipeline Bets Yahoo Finance

Does Zepbound Affect Your Period? Menstrual Cycle Changes - Ro

Does Zepbound Affect Your Period? Menstrual Cycle Changes Ro

Wegovy, Zepbound: $50 GLP-1 Drugs Are Coming for Medicare Recipients - Healthline

Wegovy, Zepbound: $50 GLP-1 Drugs Are Coming for Medicare Recipients Healthline

CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans - CNBC

CVS to restore coverage of Zepbound, add Eli Lilly's obesity pill to drug plans CNBC

CVS brings back coverage for Lilly's obesity drug Zepbound - Reuters

CVS brings back coverage for Lilly's obesity drug Zepbound Reuters

Compounded GLP-1s: Why doctors worry and the FDA is cracking down - Stanford Medicine

Compounded GLP-1s: Why doctors worry and the FDA is cracking down Stanford Medicine

This New Zepbound Study Could Be Great News for Eli Lilly Investors - Yahoo Finance

This New Zepbound Study Could Be Great News for Eli Lilly Investors Yahoo Finance

Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen - Eli Lilly

Zepbound (tirzepatide), the most prescribed weight management medication in 2025, now available in multi-dose KwikPen Eli Lilly

Millions of older Americans soon could get popular weight loss drugs for $50 a month, far less than today's prices - UCHealth

Millions of older Americans soon could get popular weight loss drugs for $50 a month, far less than today's prices UCHealth